Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 114,13
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Idioma: Inglés
Publicado por Basel, Birkhäuser Verlag, 1999
ISBN 10: 3764358971 ISBN 13: 9783764358976
Librería: Schätze & Co., Münnerstadt, KG, Alemania
EUR 89,00
Cantidad disponible: 1 disponibles
Añadir al carritoGr. 8°, Hardcover. Condición: Sehr gut. Ill., 251 S. Sprache: Englisch; sehr gutes Ex. Sprache: Englisch Gewicht in Gramm: 730.
EUR 143,08
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPaperback. Condición: New. Softcover reprint of the original 1st ed. 1999.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 186,49
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
EUR 203,95
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
EUR 186,48
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: California Books, Miami, FL, Estados Unidos de America
EUR 209,45
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
EUR 135,24
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPaperback. Condición: New. Softcover reprint of the original 1st ed. 1999.
EUR 162,51
Cantidad disponible: Más de 20 disponibles
Añadir al carritoGebunden. Condición: New.
EUR 162,51
Cantidad disponible: Más de 20 disponibles
Añadir al carritoKartoniert / Broschiert. Condición: New.
EUR 230,79
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 268.
EUR 166,90
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Proton Pump Inhibitors | Lars Olbe | Taschenbuch | x | Englisch | 2013 | Birkhäuser | EAN 9783034897778 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
EUR 229,12
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. Editor(s): Olbe, Lars. Series: Milestones in Drug Therapy. Num Pages: 261 pages, biography. BIC Classification: MB. Category: (P) Professional & Vocational. Dimension: 244 x 170 x 14. Weight in Grams: 467. . 2013. 1999th Edition. paperback. . . . .
EUR 230,66
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. This monograph contains a description of the discovery and development of a new antisecretory therapy in the treatment of acid-related diseases: omeprazole, the first pump inhibitor. The pharmacology of different proton pump inhibitors and the pharmaceutic delivery system are reviewed. Editor(s): Olbe, Lars. Series: Milestones in Drug Therapy. Num Pages: 261 pages, biography. BIC Classification: MJH; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 244 x 170 x 20. Weight in Grams: 730. . 1999. Hardback. . . . .
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 226,72
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Like New. Like New. book.
Idioma: Inglés
Publicado por Birkhäuser Basel, Birkhäuser Basel, 2013
ISBN 10: 3034897774 ISBN 13: 9783034897778
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 192,59
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists.
Idioma: Inglés
Publicado por Birkhäuser Basel, Birkhäuser Basel, 1999
ISBN 10: 3764358971 ISBN 13: 9783764358976
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 192,59
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 273,05
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. 1999 edition. 268 pages. 9.60x6.69x0.61 inches. In Stock.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 283,33
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. x + 251.
EUR 285,54
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. Editor(s): Olbe, Lars. Series: Milestones in Drug Therapy. Num Pages: 261 pages, biography. BIC Classification: MB. Category: (P) Professional & Vocational. Dimension: 244 x 170 x 14. Weight in Grams: 467. . 2013. 1999th Edition. paperback. . . . . Books ship from the US and Ireland.
EUR 287,47
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. This monograph contains a description of the discovery and development of a new antisecretory therapy in the treatment of acid-related diseases: omeprazole, the first pump inhibitor. The pharmacology of different proton pump inhibitors and the pharmaceutic delivery system are reviewed. Editor(s): Olbe, Lars. Series: Milestones in Drug Therapy. Num Pages: 261 pages, biography. BIC Classification: MJH; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 244 x 170 x 20. Weight in Grams: 730. . 1999. Hardback. . . . . Books ship from the US and Ireland.
EUR 280,12
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 270,64
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Like New. Like New. book.
EUR 306,09
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 150,28
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Idioma: Inglés
Publicado por Springer, Basel, Birkhäuser Basel Apr 1999, 1999
ISBN 10: 3764358971 ISBN 13: 9783764358976
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 181,89
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists. 251 pp. Englisch.
Idioma: Inglés
Publicado por Springer, Basel, Birkhäuser Basel, Birkhäuser Okt 2013, 2013
ISBN 10: 3034897774 ISBN 13: 9783034897778
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 192,59
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists. 251 pp. Englisch.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 238,71
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. 268 51 Illus.
Librería: preigu, Osnabrück, Alemania
EUR 168,50
Cantidad disponible: 5 disponibles
Añadir al carritoBuch. Condición: Neu. Proton Pump Inhibitors | Lars Olbe | Buch | Einband - fest (Hardcover) | Englisch | 1999 | Birkhäuser Basel | EAN 9783764358976 | Verantwortliche Person für die EU: Springer Nature c/o IBS, Benzstr. 21, 48619 Heek, tanja[dot]keller[at]springer[dot]com | Anbieter: preigu Print on Demand.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 243,03
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. 268.